Wellington Management Company »

Day One Biopharmaceuticals I shares owned by Wellington Management Company

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.1M 209k 14.60
2023-09-30 $1.4M 118k 12.27
2023-06-30 $1.3M 112k 11.94

More positions owned by Wellington Management Company

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Pfizer (PFE)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Danaher Corporation (DHR)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)

View all positions for Wellington Management Company

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
BlackRock
Vanguard Group
FMR
Franklin Resources
Viking Global Investors
Pictet Asset Management Holding SA
T. Rowe Price Associates
Braidwell
Goldman Sachs Group
Henderson Group
Deerfield Management Company
TimesSquare Capital Management
Estuary Capital Management

View all funds holding Day One Biopharmaceuticals I